Print Page  Close Window


SEC Filings

10-Q
OREXIGEN THERAPEUTICS, INC. filed this Form 10-Q on 05/12/2017
Entire Document
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

 

OREXIGEN THERAPEUTICS, INC.

 

 

 

Date: May 11, 2017

 

By:

 

/s/ Michael A. Narachi

 

 

 

 

Michael A. Narachi

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

Date: May 11, 2017

 

By:

 

/s/ Jason A. Keyes

 

 

 

 

Jason A. Keyes

SVP, Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

69